RedHill Biopharma (RDHL) Interest Coverage Ratio Growth (1y) (2013 - 2023)
Powered by 
Analysis
RedHill Biopharma (RDHL) Interest Coverage Ratio Growth (1y) (2013 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -97.39% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -85.68% |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 95.71% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -649.91% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | -11.17% |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 12,688.80% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 1,184.06% |
| Mar 31, 2023 | -1,723.72% |
| Dec 31, 2022 | 20.52% |
| Sep 30, 2022 | -94.85% |
| Jun 30, 2022 | -62.88% |
| Mar 31, 2022 | 11.39% |
| Dec 31, 2021 | -1,004.85% |
| Sep 30, 2021 | 26.75% |
| Jun 30, 2021 | 71.22% |
| Mar 31, 2021 | -92.03% |
| Dec 31, 2020 | -93.25% |
| Sep 30, 2020 | -94.40% |
| Jun 30, 2020 | -97.96% |
| Mar 31, 2020 | 436.40% |
| Dec 31, 2019 | -72.44% |
| Sep 30, 2019 | 201.44% |
| Jun 30, 2019 | 2,905.64% |
| Mar 31, 2019 | -93.38% |
| Dec 31, 2018 | -79.35% |
| Sep 30, 2018 | 146.48% |